1.Seward, JF, et al. Contagiousness of varicella in vaccinated cases – a household contact study. Journal of the American Medical Association 2004; 292: 704–708.
2.Brotherton, J, et al. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence 2007; 31 (Suppl.): S82–S101.
3.Australian Government. The Australian Immunisation Handbook, 9th edn. Australian Government, 2008, pp. 309–321.
4.Brisson, M, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiology and Infection 2001; 127: 305–14.
5.Macartney, KK, et al. Varicella vaccination in Australia. Journal of Paediatrics and Child Health 2005; 41: 544–552.
6.Vazquez, M, et al. The effectiveness of the varicella vaccine in clinical practice. New England Journal of Medicine 2001; 344: 955–956.
7.Tugwell, BD, et al. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 2004; 113: 455–459.
8.Chaves, SS, et al. Loss of vaccine-induced immunity to varicella over time. New England Journal of Medicine 2007; 356: 1121–1129.
9.Marin, M, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 2007; 56(RR-4): 1–40.
10.Marin, M, Meissner, HC, Seward, JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 2008; 122: e744–e751.
11.Gidding, HF, Brisson, M, MacIntyre, CR. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Australian and New Zealand Journal of Public Health 2005; 29: 544–551.
12.Brisson, M, et al. Modelling the impact of immunisation on the epidemiology of varicella zoster virus. Epidemiology and Infection 2000; 125: 651–669.
13.Brisson, M., Edmunds, WJ. The cost-effectiveness of varicella vaccination in Canada. Vaccine 2002; 20: 1113–1125.
14.Schuette, MC. A qualitative analysis of a model for the transmission of varicella-zoster virus. Mathematical Biosciences 2003; 182: 113–126.
15.Gidding, HF, et al. The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiology and Infection 2003; 131: 1085–1089.
16.Farrington, CP. Modelling forces of infection for measles, mumps and rubella. Statistics in Medicine 1990; 9: 953–967.
17.Brisson, M, et al. Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine 2000; 18: 2775–2778.
18.Kuter, B, et al. Ten year follow-up of health children who received one or two injections of varicella vaccine. Pediatric Infectious Disease Journal 2004; 23: 132–137.
19.Michalik, DE, et al. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. Journal of Infectious Diseases 2008; 197: 944–949.
20.Anderson, RM, May, RM. Infectious diseases of humans. Oxford, UK: Oxford University Press, 1991.
21.Brisson, M, et al. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20: 2500–2507.
22.Brisson, M, Edmunds, WJ, Gay, NJ. Varicella vaccination: Impact of vaccine efficacy on the epidemiology of VZV. Journal of Medical Virology 2003: 70: S31–S37.
23.Becker, NG, Britton, T. Estimating vaccine efficacy from small outbreaks. Biometrika 2004; 91: 363–382.
24.Halloran, ME, et al. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. American Journal of Epidemiology 1997; 10: 789–803.
25.Vessey, SJ, et al. Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy. Journal of Pediatrics 2001; 139: 297–304.
26.Arvin, A, Gershon, A. Control of varicella: why is a two-dose schedule necessary? Opinion and analysis. Pediatric Infectious Disease Journal 2006; 25: 475–476.
27.Shinefield, H, et al. Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatric Infectious Disease Journal 2005; 24: 670–675.
28.Shinefield, H, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatric Infectious Disease Journal 2005; 24: 665–669.
29.Vazquez, M, et al. Effectiveness over time of varicella vaccine. Journal of the American Medical Association 2004; 291: 851–855.
30.Oxman, MN, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older Adults. New England Journal of Medicine 2005; 352: 2271–2284.